Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Pre-operative predictors of re-intervention after endometrial ablation

From: Prediction of unsuccessful endometrial ablation: a retrospective study

  Univariate analysis Multivariate analysis  
Variable Odds ratio 95% CI p value Odds ratio 95% CI p value β
Age (years) 0.93 0.89–0.98 <.01 0.95 0.90–1.00 .06 − 0.052
Body mass index (kg/m2) 0.99 0.93–1.05 .68     
Dysmenorrhea 2.83 1.44–5.55 <.01 2.48 1.21–5.07 .01 0.097
Duration of menstruation > 7 days 1.87 1.04–3.37 .04 2.05 1.10–3.82 .02 0.718
Intermittent or irregular bleeding 1.56 0.84–2.89 .16     
Menorrhagia 0.67 0.14–3.12 .61     
Myomas 0.67 0.30–1.48 .33     
Parity (no.) 0.88 0.66–1.17 .38     
Parity ≥ 5 5.84 1.27–26.83 .02 7.63 1.51–38.46 .01 2.032
Pre-treatment* 0.40 0.16–0.95 .04 0.49 0.20–1.22 .13
Previous caesarean section 2.98 1.52–5.83 <.01 2.21 1.05–4.64 .04 0.794
Smoking 1.36 0.70–2.62 .36     
Sterilisation 1.59 0.86–2.94 .14     
Total endometrial thickness
 Thin, 0–3 mm 0.64 0.18–2.29 .49     
 Normal, 4–12 mm 1.00     
 Thick, > 13 mm 0.96 0.36–2.58 .93     
Uterine cavity length of the uterus (cm) 1.16 0.88–1.54 .29     
Uterus position
 Anteverted 1.00     
 Retroverted 1.23 0.54–2.79 .63     
 Midposition 2.77 0.70–10.96 .15     
  1. *Any form of treatment (medicamentous or surgical) prior to the EA